Hao Wang

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

Rong Fan, Jian Sun, Quan Yuan et al. · Gut · 2015 · 125 citations · Full text

Pharmacy, Immunology, Pharmacology +17

Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy

Rong Fan, Bin Zhou, Min Xu et al. · Clinical Gastroenterology and Hepatology · 2019 · 98 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Two-year Lamivudine treatment for Hepatitis B e Antigen-Negative Chronic Hepatitis B: A Double-Blind, Placebo-Controlled Trial

Henry Lik‐Yuen Chan, Hao Wang, Junqi Niu et al. · Antiviral Therapy · 2007 · 86 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Combining Hepatitis B Virus RNA and Hepatitis B Core–Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen–Positive Patients With Chronic Hepatitis B

Rong Fan, Jie Peng, Qing Xie et al. · The Journal of Infectious Diseases · 2020 · 85 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B

Minde Zeng, Yimin Mao, Guang-bi Yao et al. · Hepatology · 2006 · 73 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11